Published in Hypertension on November 01, 1998
Retracted The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem (2007) 2.60
Modifier genes for hypertrophic cardiomyopathy. Curr Opin Cardiol (2002) 1.47
Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J (2007) 1.23
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res (2009) 1.16
MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem Biophys Res Commun (2009) 0.99
Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol (2010) 0.98
Rescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes. J Mol Cell Cardiol (2010) 0.96
The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study. J Mol Diagn (2008) 0.94
RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum Genet (2007) 0.92
Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn (2000) 0.88
The renin angiotensin system and the metabolic syndrome. Open Hypertens J (2010) 0.86
Translational study of microRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond) (2012) 0.85
Functional polymorphisms in genes of the Angiotensin and Serotonin systems and risk of hypertrophic cardiomyopathy: AT1R as a potential modifier. J Transl Med (2010) 0.84
Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J (2009) 0.83
Renin-angiotensin-aldosterone system polymorphisms: a role or a hole in occurrence and long-term prognosis of acute myocardial infarction at young age. BMC Med Genet (2007) 0.83
Renin-angiotensin gene polymorphism in children with uremia and essential hypertension. Pediatr Nephrol (2002) 0.82
Cardiovascular Disease, Single Nucleotide Polymorphisms; and the Renin Angiotensin System: Is There a MicroRNA Connection? Int J Hypertens (2010) 0.81
Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective? Br J Pharmacol (2005) 0.80
Increased risk for ischaemic events is related to combined RAS polymorphism. Heart (2001) 0.80
Role and therapeutic potential of G-protein coupled receptors in breast cancer progression and metastases. Eur J Pharmacol (2015) 0.79
Temporal and morphological impact of pressure overload in transgenic FHC mice. Front Physiol (2013) 0.77
The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy. PLoS One (2013) 0.76
Associations between the deletion polymorphism of the angiotensin 1-converting enzyme gene and ocular signs of primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2004) 0.76
Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment. Neth Heart J (2005) 0.75
Role of angiotensin II type I (AT1 A1166C) receptor polymorphism in susceptibility of left ventricular dysfunction. Indian Heart J (2015) 0.75
Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies. J Biomed Sci (2017) 0.75
Genome screening by searching for shared segments: mapping a gene for benign recurrent intrahepatic cholestasis. Nat Genet (1994) 10.35
Perspectives of identity by descent (IBD) mapping in founder populations. Clin Exp Allergy (1995) 8.16
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet (1992) 5.12
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med (2000) 4.81
A clinical prediction rule for renal artery stenosis. Ann Intern Med (1998) 4.32
Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet (1992) 3.76
Linkage-disequilibrium mapping of disease genes by reconstruction of ancestral haplotypes in founder populations. Am J Hum Genet (1999) 3.16
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
Angiotensin II and the heart : on the intracrine renin-angiotensin system. Hypertension (2000) 2.26
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
Genetic heterogeneity of polycystic kidney disease in Europe. Contrib Nephrol (1992) 2.14
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet (1995) 2.11
Incorrect specification of marker allele frequencies: effects on linkage analysis. Am J Hum Genet (1993) 2.10
Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity. Clin Chem (1996) 2.02
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Br Med J (Clin Res Ed) (1982) 2.02
Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease. Nat Genet (1993) 2.01
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87
An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci U S A (1993) 1.83
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80
Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol (1993) 1.77
Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nat Genet (1996) 1.76
Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet (1999) 1.76
Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin converting enzyme mRNA expression in the human eye: evidence for an intraocular renin-angiotensin system. Br J Ophthalmol (1996) 1.74
Cardiac involvement in adults with Pompe disease. J Intern Med (2008) 1.72
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet (2001) 1.71
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Renal artery stenosis and hypertension. Lancet (1994) 1.67
Use of linkage disequilibrium approaches to map genes for bipolar disorder in the Costa Rican population. Am J Med Genet (1996) 1.65
5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Hypertension (1984) 1.58
The gene for triphalangeal thumb maps to the subtelomeric region of chromosome 7q. Nat Genet (1994) 1.56
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries. J Hypertens (2003) 1.54
Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet (2001) 1.54
Assessing the feasibility of linkage disequilibrium methods for mapping complex traits: an initial screen for bipolar disorder loci on chromosome 18. Am J Hum Genet (1999) 1.54
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
The gene for autosomal dominant spinocerebellar ataxia (SCA1) maps telomeric to the HLA complex and is closely linked to the D6S89 locus in three large kindreds. Am J Hum Genet (1991) 1.53
Score test for detecting linkage to quantitative traits. Genet Epidemiol (2002) 1.53
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol (1982) 1.51
Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br Med J (Clin Res Ed) (1981) 1.51
Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol (1989) 1.48
Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr (2004) 1.47
A complete genome screen for genes predisposing to severe bipolar disorder in two Costa Rican pedigrees. Proc Natl Acad Sci U S A (1996) 1.46
Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve Suppl (1995) 1.43
[Monotherapy with antihypertensive drugs: can a choice be made?]. Ned Tijdschr Geneeskd (1992) 1.40
Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation (1997) 1.40
[Hypertension caused by arterial fibromuscular dysplasia]. Ned Tijdschr Geneeskd (1994) 1.39
A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am J Hum Genet (2003) 1.39
Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int (2001) 1.36
Angiotensin levels in the eye. Invest Ophthalmol Vis Sci (1994) 1.36
Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab (1989) 1.35
Opposite effects of captopril on angiotensin I-converting enzyme 'activity' and 'concentration'; relation between enzyme inhibition and long-term blood pressure response. Clin Sci (Lond) (1981) 1.31
Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation (2001) 1.28
Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens (1998) 1.28
Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes. Am J Hum Genet (1995) 1.27
Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation (1998) 1.27
Angiotensin I-to-II conversion in the human renal vascular bed. J Hypertens (1998) 1.26
Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet (1987) 1.25
Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience. Neth Heart J (2007) 1.23
Infantile form of neuronal ceroid lipofuscinosis (CLN1) maps to the short arm of chromosome 1. Genomics (1991) 1.23
Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet (2001) 1.23
Slope of the instantaneous hyperemic diastolic coronary flow velocity-pressure relation. A new index for assessment of the physiological significance of coronary stenosis in humans. Circulation (1994) 1.23
Inactive renin in human plasma. Lancet (1976) 1.22
Is low-renin hypertension a stage in the development of essential hypertension or a diagnostic entity? Lancet (1975) 1.18
Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Br Med J (1980) 1.17
Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation (1998) 1.16
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab (1999) 1.16
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Br Heart J (1983) 1.15
Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia (1999) 1.14
Further localization of the gene for hereditary paragangliomas and evidence for linkage in unrelated families. Eur J Hum Genet (1994) 1.14
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14
Angiotensin II type 1 (AT1) receptor-mediated accumulation of angiotensin II in tissues and its intracellular half-life in vivo. Hypertension (1997) 1.13
Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet (1994) 1.12
Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther (1980) 1.12
Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J (1979) 1.11
Linkage analysis with chromosome 15q11-13 markers shows genomic imprinting in familial Angelman syndrome. J Med Genet (1992) 1.11
A recombination event that redefines the Huntington disease region. Am J Hum Genet (1992) 1.11
Activation of inactive plasma renin by plasma and tissue kallikreins. Clin Sci (Lond) (1979) 1.09
Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Br J Clin Pharmacol (1980) 1.08
Identification and quantification of renin and prorenin in the bovine eye. Endocrinology (1990) 1.08
Effects of 10 different beta-adrenoceptor antagonists on hemodynamics, plasma renin activity, and plasma norepinephrine in hypertension: the key role of vascular resistance changes in relation to partial agonist activity. J Cardiovasc Pharmacol (1983) 1.08
Control of enzymatically inactive renin in man under various pathological conditions: implications for the interpretation of renin measurements in peripheral and renal venous plasma. Clin Sci Mol Med (1978) 1.07
Familial prevalence of asymmetric septal hypertrophy. Eur J Cardiol (1976) 1.07
Plasma thyroxine, 3,3',5-triiodothyronine and 3,3',5'-triiodothyronine during beta-adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab (1977) 1.06
Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine. J Cardiovasc Pharmacol (1984) 1.06
Ultrasonic dynamic three-dimensional visualization of the heart with a multiplane transesophageal imaging transducer. J Am Soc Echocardiogr (1994) 1.06
Sodium restriction and potassium supplementation in young people with mildly elevated blood pressure. J Hypertens (1987) 1.06
An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees. Am J Med Genet (1996) 1.05
Prejunctional beta 1-adrenoceptors inhibit cholinergic transmission in canine bronchi. J Appl Physiol (1985) (1987) 1.05
Splint renal function after captopril in unilateral renal artery stenosis. Br Med J (Clin Res Ed) (1984) 1.04
Dimensions and volumes of left atrium and ventricle determined by single beam echocardiography. Br Heart J (1974) 1.04
Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. Am J Hum Genet (1992) 1.04
Ketanserin: haemodynamic effects and mechanism of action. J Hypertens Suppl (1986) 1.03
Significant linkage disequilibrium between the Huntington disease gene and the loci D4S10 and D4S95 in the Dutch population. Am J Hum Genet (1992) 1.03
Abnormal renal haemodynamics and renin suppression in hypertensive patients. Clin Sci (1970) 1.02
A genome-wide scan in type 2 diabetes mellitus provides independent replication of a susceptibility locus on 18p11 and suggests the existence of novel Loci on 2q12 and 19q13. J Clin Endocrinol Metab (2003) 1.02